Clinical TrialsSearch results
Number of results: 1091
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning
- Chronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphoma
- Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare
- 2005-10-01
Other
- A phase II basket study of necitumumab for EGFR amplification positive m etastatic solid tumor : WJOG15021M
- Esophageal cancer, gastric cancer, small intestine cancer, urothelial cancer, breast cancer
- Nakanishi Kouki
- 2022-10-07
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- A phase II study for anaplastic thyroid cancer
- anaplastic thyroid cancer
- Nagoya university hospital
- 2006-09-01
Other
- A Phase II Study of Cisplatin, Etoposide and Concurrent Thoracic Irradiation Followed by Irinotecan and Cisplatin in Patients with Limited Small-Cell Lung Cancer
- LD-SCLC
- West Japan Oncology Group
- 2005-09-02
Other
- A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer
- Thymic cancer
- West Japan Oncology Group
- 2008-09-08
Other
- A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- West Japan Oncology Group
- 2008-09-12
Other
- A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.
- Non-Small-Cell Lung Cancer
- Central Japan Lung Study Group
- 2009-04-08
Other
- A phase II study of gemcitabine and S-1 combination therapy for metastatic pancreatic cancer
- Metastatic pancreatic cancer
- National Cancer Center Hospital, Hepatobiliary and Pancreatic Oncology Division
- 2005-10-01